FDA Approves First-of-Its-Kind Chronic Hepatitis B Treatment
The FDA approved bepirovirsen injection under the brand name Hibsago to treat chronic hepatitis B virus infection in adults without cirrhosis.
The FDA approved bepirovirsen injection under the brand name Hibsago to treat chronic hepatitis B virus infection in adults without cirrhosis.